Guerbet announced that its Lipiojoint transient liquid embolic agent received Breakthrough Device status from the United State ...
CereVasc, Inc. announced the initial results of its United States pilot clinical study of the CereVasc eShunt system in the ...
Medtronic announced that new findings from the company-sponsored DiVERT Stroke clinical study showed women spent less time in t ...
Arsenal Medical announced the completion of the initial cohort enrollment in the EMBO-02 clinical study of the company’s ...
The American Stroke Association (ASA) announced the presentation of the DISTAL study, which is investigating whether endovascul ...
Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...
Chronic limb-threatening ischemia (CLTI) is a challenging disease to treat, requiring a tailored approach and comprehensive endovascular toolbox. The goal of treatment is to achieve wound healing, ...
Management of ALI includes anticoagulation, open thrombectomy, surgical bypass, catheter-directed thrombolysis (CDT), endovascular thrombectomy, and a combination of open and endovascular techniques.
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...